Direct costs of ankylosing spondylitis and its determinants: an analysis among three European countries.
Fiche publication
Date publication
août 2003
Journal
Annals of the rheumatic diseases
Auteurs
Membres identifiés du Cancéropôle Est :
Pr GUILLEMIN Francis
Tous les auteurs :
Boonen A, van der Heijde D, Landewé R, Guillemin F, Rutten-van Mölken M, Dougados M, Mielants H, de Vlam K, van der Tempel H, Boesen S, Spoorenberg A, Schouten H, van der Linden S
Lien Pubmed
Résumé
To assess direct costs associated with ankylosing spondylitis (AS). To determine which variables, including country, predict costs.
Mots clés
Adolescent, Adult, Aged, Antirheumatic Agents, economics, Belgium, Cost of Illness, Direct Service Costs, statistics & numerical data, Drug Costs, Female, Follow-Up Studies, France, Health Expenditures, statistics & numerical data, Health Services, utilization, Humans, Male, Middle Aged, Netherlands, Prospective Studies, Severity of Illness Index, Spondylitis, Ankylosing, economics, Statistics as Topic, Surveys and Questionnaires
Référence
Ann. Rheum. Dis.. 2003 Aug;62(8):732-40